Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
doi 10.5455/2319-2003.ijbcp20140805
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medip Academy

Related search

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus

Cureus
2017English

Practice of Dapagliflozin Application in Patients With Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2015English

Fournier’s Gangrene in a Patient on Dapagliflozin Treatment for Type 2 Diabetes

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Pdb81 - Dapagliflozin Is Cost-Effective Compared to DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Clinical Study on Adverse Drug Reactions of Combination Therapy of Dapagliflozin and Metformin in the Treatment of Type 2 Diabetes Mellitus

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Sulfonylureas in the Treatment of Type 2 Diabetes Mellitus: A Fresh Look and New Insights

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Honey as a Sole Treatment of Type 2 Diabetes Mellitus

Endocrinology & Metabolic Syndrome
2016English

Vildagliptin: Optimal Control in Type 2 Diabetes Mellitus Treatment

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Considering Gut Microbiota in Treatment of Type 2 Diabetes Mellitus

Gut Microbes
Infectious DiseasesMicrobiologyGastroenterology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy